Covered recipient · General Payments record
JACQUELINE M MAHADY SMITH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$454.11
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $298.51 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $148.13 | 8 |
| GlaxoSmithKline, LLC. | $46.82 | 2 |
| OptiNose US, Inc. | $38.35 | 2 |
| Kaleo, Inc. | $33.39 | 2 |
| Regeneron Healthcare Solutions, Inc. | $16.03 | 1 |
| AERIN MEDICAL INC. | $15.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AERIN MEDICAL INC. | $15.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144644583 | CMS |
| GENZYME CORPORATION | $26.65 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912485 | CMS |
| GENZYME CORPORATION | $9.50 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912495 | CMS |
| GENZYME CORPORATION | $23.04 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912509 | CMS |
| GENZYME CORPORATION | $13.21 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912537 | CMS |
| GENZYME CORPORATION | $16.48 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912549 | CMS |
| GENZYME CORPORATION | $14.72 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912595 | CMS |
| GENZYME CORPORATION | $24.07 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912615 | CMS |
| GENZYME CORPORATION | $20.46 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139912619 | CMS |
| GlaxoSmithKline, LLC. | $27.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116711415 | CMS |
| GlaxoSmithKline, LLC. | $19.48 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116232593 | CMS |
| kaleo, Inc. | $17.29 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126632752 | CMS |
| kaleo, Inc. | $16.10 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126632754 | CMS |
| Optinose US, Inc. | $22.14 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142183542 | CMS |
| Optinose US, Inc. | $16.21 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142183536 | CMS |
| Regeneron Healthcare Solutions, Inc. | $16.03 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114336103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.